We will not let hate suppress the success of others. We want to recognise the incredible achievements of the England #football team, and the hard work and strength they've inspired. They should be celebrated.

Everyone, whatever your profession, should have the support and freedom to excel.

We condemn the vicious and racist abuse of all professionals, whether that's online or otherwise, and stand in solidarity with other organisations and leaders who empower success unconditionally.

Today we announce our results for the financial year to 30 April 2021.

The firm has seen a 12% increase in UK revenue to £175.5m and a 23% increase in UK profit to £71m. UK profit per equity partner is 18% up on last year.

Cambridge, UK, 15 July 2021 – PharmEnable, an AI drug discovery company unlocking challenging biological targets, announces that it has entered into a drug discovery collaboration with LifeArc, an independent UK medical research charity, to apply their respective technologies and expertise to discover novel oral antiviral drugs with activity against coronaviruses.

AMSBIO has established an unmatched commercial biorepository and procurement network that includes a large selection of fully characterized and annotated Formalin-Fixed Paraffin-Embedded (FFPE) tissue blocks to help streamline your research.

The Biosphere, a specialist lab facility on Newcastle Helix is hosting an online careers event aimed at graduates and postgraduate research students who are looking to make the transition from academia to industry.

The event will see representatives from a range of companies who are based in The Biosphere. They will share their own experiences, personal journey, top tips, and industry insight. They will also showcase some of the exciting job opportunities available to those looking to base themselves in North East.

Today we announce the completion of our permanent office space in the Edward Pavilion building in Liverpool's vibrant and iconic Royal Albert Dock.

The completion of the project follows the signing of a ten-year lease in February 2020 and underlines our long-term commitment to the city and its communities.

Since establishing a presence in Liverpool in November 2018, the firm has built a team of 100+ legal and business experts, and has a growing reputation as an employer of choice for outstanding talent in the region.

We have advised the Global EdTech startup, Unibuddy on its US$20 million Series B investment.

Unibuddy is the number one peer-to-peer university recruitment platform that has helped 770,000 students from over 180 countries make better decisions about their higher education journey. The platform works with 450+ higher education institutions worldwide, from the University of Cambridge (UK) and the University of Southern California (US) to Taylor’s University (Malaysia) and Bond University (Australia).

Stevenage, UK, 7 July 2021 – NeRRe Therapeutics, a clinical-stage company developing orvepitant, its wholly-owned neurokinin-1 (N

UK Life Sciences Vision sets 10-year strategy for sector to solve some of the biggest healthcare problems of our generation, including cancer and dementia.